Gene Signal promise for topical AMD antisense treatment
This article was originally published in Scrip
Executive Summary
Gene Signal's topical anti-angiogenic eye therapy aganirsen could be effective in preventing vascularisation at the back of the eye, new data suggest, potentially opening up a new way of treating diseases such as wet AMD and ischaemic retinopathy.